Oncology is not a push-over among the numerous branches of medicine. It centers on the diagnosis, prevention and treatment of cancer and some other related diseases. The plague of cancer is ravaging the world on a most worrisome proportion than ever before. The young are not exempted even though majority of cancer cases reside with the aged. Since we all pray to live long to enjoy the fruits of our labor, more effort must be jeered towards combating and putting a stop to the spread of this menace. This is where we need oncologists to take the center stage and give us the victory we earnestly desire. Mikhail Blagosklonny has proven beyond all doubts that he has what it takes to do just that.
Mikhail had always wanted to be an Oncologist of repute even while he was still in college. He made this explicitly clear to all and sundry when he took to medical school at the prestigious First Pavlov State Medical University of St. Petersburg where graduated with a MD in Internal Medicine and PhD in Experimental Medicine and Cardiology.
He knew he needed a comprehensive working experience, so he had to strategize. He turned down some job opportunities that were capable of distancing him from his goal of being an erudite professor of Oncology. It is thus not an accident that he eventually worked and still works in some of the best medical institutions that address issues relating to cancer. The likes of New York Medical College, Ordway Research Institute and the Roswell Park Cancer Institute are some of the best medical instituting focusing on cancer. Mikhail Blagosklonny spent quality time working in all three and he is still with the Roswell Park Cancer Institute as an erudite professor of Oncology.
Make no mistake about it, his professorship is well deserved. He has distinguished himself as a force to be reckoned with in the field of Oncology. The world had no choice but to sing his praise when he formulated a theory on TOR signaling, which dealt fatal blows on the monster called cancer and aging. He gave unflinching support to the use of rapamycin as a veritable cancer drug, which could also be used to slow down the aging process making people enjoy longer life spans.
Also Mikhail Blagosklonny has endeared himself to millions of people in and out of the United States as his articles, books and reviews keep moving from one continent to the other. Many who could not meet him in person, have come to know much about cancer, its prevention and treatment options through his writings.
Mikhail Blagosklonny has so far proven that the status of a professor of Oncology must not stop at the name,but be justified with exploits that transcend national boundaries. Visit ResearchGate to keep up to date with Mikhail’s latest work.